Clinical trial
Impact of Age on Oncologic Outcomes After BCG Therapy in Primary pT1 High-Grade Bladder Cancer: A Retrospective Multicenter Cohort Study
NCT07798479 is registered in ClinicalTrials.gov with Insel Gruppe AG, University Hospital Bern as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impact of Age on Oncologic Outcomes After BCG Therapy in Primary pT1 High-Grade Bladder Cancer: A Retrospective Multicenter Cohort Study
- Lead sponsor
- Insel Gruppe AG, University Hospital Bern
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 1, 2009
- Completion date
- May 31, 2024
- Enrollment
- 64 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
bladder cancer, nmibc